Cipher Pharmaceuticals (CPH) Stock Price, News & Analysis

Company Overview

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.

Key Stats

• Today's Range: C$13.32 to C$13.40
• 50-Day Range: C$12.10 to C$14.56
• 52-Week Range: C$8.18 to C$19.69
• Volume: 5,833 shs
• Average Volume: 29,752 shs
• Market Capitalization: C$239.32 million
• P/E Ratio: 14.72
• Dividend Yield: N/A
• Price Target: C$14.75
• Consensus Rating: Moderate Buy

CPH Stock Analysis - Frequently Asked Questions

How have CPH shares performed this year?

Cipher Pharmaceuticals' stock was trading at C$14.32 on January 1st, 2025. Since then, CPH stock has decreased by 6.9% and is now trading at C$13.33.

How were Cipher Pharmaceuticals' earnings last quarter?

Cipher Pharmaceuticals Inc. (TSE:CPH) posted its earnings results on Thursday, August, 10th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.15 by $0.01. The company had revenue of $7.10 million for the quarter, compared to analysts' expectations of $7.46 million. Cipher Pharmaceuticals had a trailing twelve-month return on equity of 17.93% and a net margin of 59.92%.
Read the conference call transcript.

How do I buy shares of Cipher Pharmaceuticals?

Shares of CPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Cipher Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cipher Pharmaceuticals investors own include Cipher Pharmaceuticals (CPHRF), Enbridge (ENB), Bellatrix Exploration (BXE), Crescent Point Energy (CPG), Manulife Financial (MFC), Surge Energy (SGY) and Toronto-Dominion Bank (TD).

Company Calendar

• Last Earnings: 8/10/2023
• Today: 7/09/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:CPH
• Previous Symbol: TSE:DND
• CIK: N/A
• Web: www.cipherpharma.com
• Phone: +1-905-6025840
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Cipher Pharmaceuticals: C$14.75
• High Price Target: C$17.00
• Low Price Target: C$12.50
• Potential Upside/Downside: +10.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): C$0.91
• Trailing P/E Ratio: 14.72
• Forward P/E Ratio: 10.33
• P/E Growth: N/A
• Net Income: C$11.41 million
• Net Margins: 59.92%
• Pretax Margin: N/A
• Return on Equity: 17.93%
• Return on Assets: 7.90%

Debt

• Debt-to-Equity Ratio: 41.22
• Current Ratio: 2.00
• Quick Ratio: 2.67

Sales & Book Value

• Annual Sales: C$19.03 million
• Price / Sales: 12.57
• Cash Flow: C$3.78 per share
• Price / Cash Flow: 3.53
• Book Value: C$3.96 per share
• Price / Book: 3.37

Miscellaneous

• Outstanding Shares: 17,953,309
• Free Float: N/A
• Market Cap: C$239.32 million
• Optionable: Not Optionable
• Beta: 1.20